RADIOFREQUENCY ABLATION REFLUX TESTING AND TREATMENT
Radiofrequency ablation is a proactive treatment for patients diagnosed with Barrett’s oesophagus who want to reduce their risk of progression to oesophageal cancer.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.
Radiofrequency ablation is a proactive treatment for patients diagnosed with Barrett’s oesophagus who want to reduce their risk of progression to oesophageal cancer.
Barrett’s oesophagus is the primary risk factor for oesophageal adenocarcinoma (EAC), a form of oesophageal cancer. Developing Barrett’s increases your chances of developing EAC by 50 times.1 Patients with confirmed low-grade dysplasia and other risk factors face a substantial risk of disease progression.2,3
Radiofrequency ablation (RFA) is a proactive treatment for patients diagnosed with Barrett’s oesophagus who are under surveillance but want to reduce their risk of progression to EAC. Multiple studies demonstrate the effectiveness of RFA in treating Barrett’s oesophagus.4-8
Radiofrequency ablation (RFA) uses heat to remove precancerous tissue damaged by Barrett’s oesophagus. Radiofrequency ablation technology is designed for the removal of tissue affected by Barrett’s, while preserving the underlying healthy tissue.
Follow the instructions specified by your physician or the nursing staff. The following instructions were given to patients in certain clinical trials and are provided here as an example of what you can expect:
Ablation therapy is performed in conjunction with an upper endoscopy. The treatment is performed after the patient is sedated in an outpatient setting and no incisions are involved. While procedure time in clinical studies averaged 30 minutes, the actual time can vary depending on the physician’s experience and the difficulty of the case. You will be monitored after the procedure is complete.
Follow the discharge instructions provided by your physician after the RFA procedure. You may experience mild discomfort after the procedure, and your doctor may provide medications to help with your symptoms.
Your physician will schedule a follow-up appointment within two to three months after the procedure. If any residual Barrett's tissue is found, your physician will ablate it. Regular monitoring with endoscopies and biopsies are recommended even after radiofrequency ablation therapy.